We’re launching a video series: Partnering on the Edge: The Hard Work of Partnering Well. As part of our deep and long-standing engagement with ASAP, it will be made available to the ASAP community as sponsored content as well as on our YouTube channel and...
Biopharma leaders already understand the industry’s business model has fundamentally shifted. Partnering isn’t an adjunct to internal R&D or a strategic lever pulled selectively. It is the operating model. The work of discovering, developing, and delivering...
Biopharma alliances succeed or fail for reasons that are often misunderstood. Many leaders still assume that partner selection, strategic fit, or agreement quality determine performance. These factors matter, but they do not explain why alliances with similar science,...
In today’s biopharma landscape, complexity is the constant. Portfolios are expanding—not just in size, but in diversity. Collaborations span research to commercialization, startups to multinationals, and molecules to digital platforms. Meanwhile, tightening budgets,...
The biopharmaceutical environment is defined by uncertainty and turbulence. Indiscriminate and sudden cancellation of research grants, workforce contractions, shifting regulatory and policy landscapes, and supply chain instability have become the new reality. Add...
We certainly aren’t clairvoyant, although we have a crystal ball that sits on a shelf in our library. If you try to look through it, what you see is pretty murky. To the contrary, we believe the future for alliance management is coming into focus. Collaboration is the...
Many companies rely on partnering today for significant portions of pipeline and revenue. Here’s how they can get better at it. Across the biopharma industry, we see that an increasingly diverse ecosystem of organizations are involved in identifying new drug...
We’ve made the point that companies today need an organizational partnering capability just as they need a financial or talent development capability. To know the contours of what that capability needs to be, look to the company’s partnering strategy. Every company...
The March 28, 2024 ASAP Webinar shared the journey savvy alliance leaders are taking to evolve their practices from a standalone function to an organizational capability. This evolution in impact and influence is essential, given that partnering is central today to...
Partnering and alliances are easy! Two or more companies decide they want to do something together and they just do it. Right? Not really. Because alliances combine the different strategies, structures, cultures, and processes of the partners, it takes skill and...
Tipping Point. A concept that describes the point at which an issue, idea, practice, or technology reaches critical mass of acceptance and gains momentum toward widespread adoption. Partnering as a core component of corporate strategy has achieved this point and has...
There is no question 2023 is a challenging year for biopharma companies. Pipelines are being culled. Financing for early-stage companies is harder to come by. A number of blockbusters are losing exclusivity. M&A activity is picking up. For biopharmaceutical...